With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

Molecular Instruments® (MI), inventor of the HCRtm technology, today announced the availability of fully ambient-temperature HCRtm Pro RNA-ISH on the BOND-III, introducing a new class of ...

Two separate laboratory breakthroughs have produced RNA molecules that can build copies of themselves or assemble functional structures without any help from proteins or DNA. These results offer the ...

Molecular Instruments® (MI), inventor of the HCR™ technology, today announced the availability of fully ambient-temperature ...

Researchers engineered RNA micelles carrying gemcitabine, survivin-targeting siRNA and a tumor-binding ligand. In mice with ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

Researchers are embarking on the RNA equivalent of the Human Genome Project, including sequencing all the chemical ...

Molecular Instruments launches fully ambient-temperature HCR Pro RNA-ISH on the BOND-III, marking a new generation of clinical-grade RNA-ISH designed to reduce heat-driven variability ...

WOBURN, MA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Powered by AFA‑enabled workflows that deliver ...

Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative ...

Researchers have developed a near-single-cell resolution spatial transcriptomic approach to study developmentally regulated RNA processes.